If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).




schemaVersion:


SCHEDULE 13D




Comment for Type of Reporting Person:
The number of shares beneficially owned by the Reporting Person consists of: (i) 8,794,875 common shares and (ii) 137,693 Shares that may be issued on exercise of Options, of which 47,693 are exercisable at a price of C$6.50 per Share of which 47,693 are exercisable at a price of C$6.50 per Share of which all options have vested and 90,000 are exercisable at a price of C$13.50 per Share of which 52,500 options have vested and 7,500 options will vest within the next 60 days. Percent of class represented by amount in Row (11) is calculated based on the aggregate of 35,871,442 common shares, which consists of 35,733,749 common shares of the Issuer outstanding as at September 28, 2026 and 137,693 common shares that may be acquired on exercise of stock options.


SCHEDULE 13D


 
Avshalom Ofer Vicus
 
Signature:Avshalom Ofer Vicus
Name/Title:CEO, Chairman and Director
Date:09/28/2026